Scilex Holding, a subsidiary of bankrupt drugmaker Sorrento Therapeutics, said it filed an emergency motion in bankruptcy court related to its allegations that possible naked short selling of Scilex has taken place, MarketWatch.com reported. The company is seeking "production of books and records from certain brokers, dealers, banks and other nominees." Scilex, which focuses on non-opioid pain management drugs, said earlier this month that it retained Warshaw Burstein and Christian Attar Law to investigate potential naked short selling and market manipulation.
